Skip to main content
Equibles

SCTX · Scribe Therapeutics, Inc. · Debt

Track SCTX — free

Use SCTX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$31.90 +3.23 (+11.27%)
Rebalance outlook locked
Going-concern doubt — cleared Sep 2, 2026

The latest filing states the doubt was alleviated.

“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”
View the 10-Q filed Sep 2, 2026
Market Cap
$542.77M
Shares
18.93M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1853921 CUSIP 811033109 Visit website Investor relations